Lanean...
Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
BACKGROUND: Glioma is a primary malignancy of the central nervous system (CNS). As biomedicine advances, an efficient molecular target is urgently needed for the diagnosis and treatment of glioma. Meanwhile, several studies have demonstrated that glioma development is closely related to immunity. PA...
Gorde:
| Argitaratua izan da: | CNS Neurosci Ther |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366751/ https://ncbi.nlm.nih.gov/pubmed/32678519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13380 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|